Sitemap
En
Invest in TEDA
Strategic Opportunities
Industrial Competitiveness
Soft Advantages
Current Location: Home > Invest in TEDA > Industrial Competitiveness > Pharmaceuticals & Big Health
Industrial Competitiveness
Pharmaceuticals and Big Health    

Overview

·China’s No.1 Production Base of Insulin and Enzymes

·China’s No.1 Production Base of Instant Food and Drinking Water

With 49.3 billion yuan yielded from its big health industry in 2019, TEDA is home to accumulatively over 800 such companies.


After 30 years of development, five major industrial clusters have been formed in the fields of biopharmaceutical, medical instruments, pharmaceutical R&D outsourcing, food and drink, and big health.

Biopharmaceuticals

Medical Instruments


Pharmaceutical R & D Outsourcing

Food and Drink


Big Health


Development Goals

TEDA aims to take the opportunity of being selected as one of the first batch of national-level biomedicine strategic emerging industrial clusters, take full advantage of the free trade zone policies, and take the lead in development in the fields of pharmaceutical R&D outsourcing, establishment of wholly-owned hospitals, and drug e-commerce procurement.

It tries to guide and encouraging existing chemical and pharmaceutical companies to adjust and transform, promote the transformation of green production technology, and accelerate the development of high-end customized products.

It keeps up with the demands of consumption upgrading, develop high-end functional food centered by healthy and organic food, and gather industrial leading enterprises.

It promotes the in-depth integration of “Internet plus” with medical institutions in the area, and try establishing a standard demonstration system of “Internet + medicine and health”.


Pharmaceuticals and Big Health


Overview


·China’s No.1 Production Base of Insulin and Enzymes

·China’s No.1 Production Base of Instant Food and Drinking Water


With 49.3 billion yuan yielded from its big health industry in 2019, TEDA is home to accumulatively over 800 such companies.




After 30 years of development, five major industrial clusters have been formed in the fields of biopharmaceutical, medical instruments, pharmaceutical R&D outsourcing, food and drink, and big health.


Biopharmaceuticals




Medical Instruments




Pharmaceutical R & D Outsourcing



Food and Drink




Big Health




Development Goals


TEDA aims to take the opportunity of being selected as one of the first batch of national-level biomedicine strategic emerging industrial clusters, take full advantage of the free trade zone policies, and take the lead in development in the fields of pharmaceutical R&D outsourcing, establishment of wholly-owned hospitals, and drug e-commerce procurement.


It tries to guide and encouraging existing chemical and pharmaceutical companies to adjust and transform, promote the transformation of green production technology, and accelerate the development of high-end customized products.


It keeps up with the demands of consumption upgrading, develop high-end functional food centered by healthy and organic food, and gather industrial leading enterprises.


It promotes the in-depth integration of “Internet plus” with medical institutions in the area, and try establishing a standard demonstration system of “Internet + medicine and health”.


Website Identification Code: 1201160062

Are you sure you want to leave this page?